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eft Ventricular End-Diastolic
olume Is Normal in
atients With Heart Failure
nd a Normal Ejection Fraction
Renewed Consensus
n Diastolic Heart Failure*
ichael R. Zile, MD, FACC,†
artin M. LeWinter, MD, FACC‡
harleston, South Carolina; and Burlington, Vermont
he study published in this issue of the Journal by Maurer
t al. (1) provides data which, interpreted in the context of
number of recently published studies (2–8), allow us to
onclude that: 1) left ventricular (LV) end-diastolic volume
EDV) is normal in the vast majority of patients with heart
ailure (HF) and a normal ejection fraction (HFNEF) (i.e.,
iastolic heart failure [DHF]); 2) the pathophysiology
nderlying the vast majority of patients with HFNEF
DHF) primarily reflects the development of progressive
iastolic dysfunction.
See page 972
hese data allow us to come full circle from consensus to
ontroversy back to consensus in our understanding of
atients with DHF.
he consensus. In 2004, a group of HF investigators and
linical scientists met in Woodstock, Vermont, and devel-
ped a consensus document that stated: “. . . it was agreed
hat patients with LV failure present in 1 of 2 broad
ategories. One type exhibits a low ejection fraction with
ncreased end diastolic volume and preserved or reduced
troke volume. This presentation (has) traditionally (been)
alled systolic heart failure. . . The second group has normal
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Charles Ezra Daniel Professor of Medicine, Division of Cardiology and
he Gazes Cardiac Research Institute, Department of Medicine, Medical University
f South Carolina and RHJ Department of Veterans Affairs Medical Center,
harleston, South Carolina; and ‡Professor of Medicine and Molecular Physiologya
nd Biophysics, Cardiology Unit, Department of Medicine, University of Vermont,
urlington, Vermont.r near-normal LV diastolic volume and preserved ejection
raction. This presentation (has) traditionally (been) called
iastolic heart failure” (9). This consensus document did not
ecommend any change in current HF nomenclature: sys-
olic HF and DHF.
he controversy. The consensus view that patients with
FNEF (or DHF) have a normal or near-normal EDV
ecame a point of controversy in 2005. Among otherwise
onsistent data from multiple investigators and studies,
ome divergent data were reported (Table 1) (1,10,11). In 1
nalysis, control subjects were compared with patients with
ypertension and no HF, and patients with hypertension
nd HFNEF (10). In this analysis, it was reported that
atients with hypertension and HFNEF had a 40% larger
V EDV compared with normal controls. This difference in
DV appeared to be driven by differences in the LV
nd-diastolic long-axis dimension (EDL), which was
reater by an average of 16 mm; the short-axis end-diastolic
imension (EDD) was 1 mm smaller than normal controls.
In a subsequent analysis, patients with HFNEF were
ivided into those with and those without a history of
ypertension (11). In this analysis, patients with HFNEF
ithout hypertension had similar EDV compared with
ormal control subjects. This normal LV EDV resulted
rom a smaller EDD and a larger EDL than normal control
ubjects. By contrast, patients with HFNEF and hyperten-
ion had larger EDV, by an average of 24%, compared with
ormal control subjects. Again, the larger EDV was driven
y differences in EDL, which was 6 mm larger, while EDD
ctually was 1 mm smaller than normal control subjects.
onsensus redefined. In the study published in this issue
f the Journal, the Cardiovascular Health Study Data Base
as used to compare selected control subjects to patients
ith hypertension and no HF and patients with hyperten-
ion and HFNEF. In patients with hypertension and
FNEF, the mean value of LV EDV (calculated from an
-mode echocardiographic measurement of LV minor-axis
DD) was larger by 14%, and the mean value of LV EDD
as larger by 3 mm compared with normal controls. Left
entricular EDL was not measured in this study. While
xamination of group averages raises the question of a
omewhat larger EDV in patients with HFNEF, examina-
ion of the frequency distribution of the data clearly estab-
ish that the majority, in fact 90%, of patients with hyper-
ension and HFNEF had EDV values that fell within the
ormal range.
A standard method of establishing a “normal range” in
ny data set is to use the mean  2 SDs from the mean.
ased on this definition, the normal range for LV EDD in
his study was 4.0 to 6.0 cm. From their analysis, the
uthors concluded that the difference in EDV “. . . does not
reclude a significant proportion of the values for left
entricular diastolic diameter in the HFNEF population
emaining within the normal or reduced range even when
djusted for age, gender, body size and race. Increased
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March 6, 2007:982–5 Editorial Commententricular diameter in the heart failure normal ejection
raction group of subjects might also be explained by the
resence of a few subjects with large ventricles not repre-
entative of the remainder of the heart failure normal
jection fraction group.” In actuality, the data show that only
0% of the patients with hypertension and HFNEF had an
V EDD that exceeded the normal range. Although this
an be discerned in Figure 1 of their report, to make this
oint more clearly, we modified this figure to indicate the
ormal range and identify those patients with HFNEF who
all outside the normal range (Figs. 1 and 2). It seems very
Figure 1 Histogram of Distribution of LVIDd
Normal control subjects are compared with subjects with hypertension and no
heart failure (HTN) and subjects with hypertension heart failure and a normal
ejection fraction (HFNEF). The normal range for left ventricular internal end-dia-
stolic short-axis diameter (LVIDd) is marked above the graph as mean  2
standard deviations (StDevs) for the control group (this encompasses the 95%
confidence intervals).
hree Sets of Data Analysisrom Pr vious Publications
Table 1 Three Sets of Data AnalysisFrom Previous Publications
Subject Group EDV EDD EDL % 1 in EDV
Vest et al. (10)
Controls 88 24 4.6 0.7 10.3 1.4
Hypertension no HF 117 29 5.1 0.4 10.3 1.4
Hypertension HFNEF 124 33 4.5 0.7 11.8 1.9 40
Maurer et al. (11)
Controls 95 21 4.7 0.5 10.6 1.1
No hypertension HFNEF 98 25 4.0 0.8 11.4 1.1
Hypertension HFNEF 118 29 4.6 0.5 11.2 1.2 24
Maurer et al. (1)
Controls 109 27 4.8 0.6
Hypertension no HF 110 28 4.9 0.6
Hypertension HFNEF 124 38 5.1 0.8 14
ach set of data was taken from the reference listed.
EDD  left ventricular end-diastolic short-axis dimension; EDL  left ventricular end-diastolic
ong-axis dimension; EDV left ventricular end-diastolic volume; HF heart failure; HFNEF heart
ailure with a normal ejection fraction; % 1 in EDV  percent increase in LV EDV in the
ypertension HFNEF group compared with the normal control group.aikely that if a similar frequency distribution analysis had
een performed in previous studies, similar results would
ave been obtained. Therefore, these data and this inter-
retation allow us to return to a consensus emphasizing that
he great majority of patients with HFNEF have a normal
V EDV. These conclusions can be applied to the general
opulation of patients with HFNEF or DHF because most
atients with this diagnosis have hypertension.
uthors versus editorialist conclusions. It should be made
lear that the authors of the current study propose a somewhat
ifferent interpretation of their data than the authors of this
ditorial. The authors of the current Journal study propose the
ollowing conclusions: “As a group, HFNEF subjects have
ncreased LV diastolic diameter. . . These data suggest extra-
ardiac factors, via volume overload, may contribute to the
athophysiology of HFNEF. . .” However, there is an im-
ortant difference between the conclusion that the mean LV
DV in patients with HFNEF or DHF is increased by 10%
o 15% and the conclusion that only 10% to 15% of patients
ave an increased LV EDD. Exceptions to the rule are the
orm in clinical medicine. Thus, it is hardly surprising that
his group of patients, with significant comorbidities such as
iabetes mellitus, renal insufficiency, coronary heart disease,
nd anemia, includes a small proportion with an increased
DD. Moreover, the finding that a few patients have an
DD greater than normal does not provide insight into the
athophysiology underlying the development of HF in the
ast majority of patients with HFNEF or DHF. In contrast,
he finding that 90% of these patients had an LV EDD
ithin the normal range provides pathophysiological infor-
ation crucial to the development of diagnostic, prognostic,
Figure 2 Gaussian Distribution of LVIDd
Frequency distribution of LVIDd demonstrating that 5% of the control subjects
had an LVIDd larger than the upper limits of normal and 15% of the HFNEF
subjects had an LVIDd larger than the upper limits of normal. Therefore, only
10% of the HFNEF subjects had an LVIDd larger than expected for the control
group. Abbreviations as in Figure 1.nd therapeutic tools in patients with DHF.
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Editorial Comment March 6, 2007:982–5mportance of this redefined consensus. Why is a con-
ensus regarding LV EDD and EDV important in patients
ith DHF?
. Pathophysiology: previous studies have clearly demon-
strated that a dominant pathophysiological mechanism
in patients with DHF is abnormal diastolic function:
specifically, slowed relaxation, increased diastolic cham-
ber stiffness (increased slope of the diastolic pressure-
volume relationship), and/or decreased diastolic disten-
sibility (increased diastolic pressure, with no change in
diastolic volume, with or without a change in the slope
of the diastolic pressure-volume relationship) (2–8,12–
15). As shown in Figure 3, when LV end-diastolic
pressure increases with little or no change in volume,
this indicates a decrease in LV diastolic chamber dis-
tensibility (point A vs. C). However, if both diastolic
pressure and volume increase in a coordinate fashion
along a normal diastolic pressure-volume relationship,
this indicates that LV chamber distensibility has not
changed (point A vs. B). The diastolic pressure-volume
relationship has been measured directly in only 1 study
in patients with definite DHF (3). This study showed
that patients with DHF have decreased LV diastolic
distensibility and increased LV diastolic stiffness. The
validity of these data has not been challenged. However,
some investigators have proposed an alternate hypoth-
Figure 3 Schematic Representations of Possible Diastolic
Pressure-Volume Relationships in Heart Failure
The normal end-diastolic pressure-volume point is marked as point A. When
diastolic pressure increases with little or no change in volume, this indicates a
decrease in left ventricular (LV) chamber diastolic distensibility (point A vs. C).
However, if both diastolic pressure and volume increase in a coordinate fash-
ion along a normal diastolic pressure-volume relationship, this indicates that
LV chamber distensibility has not changed (point A vs. B). However, even in the
presence of an increased LV end-diastolic volume (EDV), the LV pressure-vol-
ume curve can be displaced upward indicating decreased distensibility (point A
vs. D). Thus, an increased LV EDV does not exclude decreased distensibility.
Data from the current and previous studies suggest that the vast majority of
patients with heart failure and a normal ejection fraction (HFNEF) or diastolic
heart failure (DHF) have a diastolic pressure-volume relationship represented
by the curve that intersects point C.tesis: not all patients with HFNEF have decreased
distensibility, particularly those with increased LV
EDV. To date, no data have been presented to support
this hypothesis, and no direct measurements of diastolic
function or diastolic pressure were made in the current
study. Consequently, this study cannot be used to
evaluate this alternate hypothesis. Even in the presence
of an increased LV EDV, the LV pressure-volume curve
can be displaced upward indicating decreased distensi-
bility (point A vs. D). Thus, an increased LV EDV does
not exclude decreased distensibility. Therefore, both
previous and current studies support the consensus that
there are dominant abnormalities in diastolic function in
the majority, if not all patients, with DHF or HFNEF.
. Treatment: to date, no randomized clinical trial has de-
fined a clearly effective management strategy to reduce
mortality and morbidity in patients with DHF. Develop-
ing effective management will depend on defining the
correct target(s) for therapy. In systolic HF, increased
EDV (and eccentric remodeling) has been shown to be an
important therapeutic target (1). Current and previous data
make it clear that EDV should not be the target for DHF
(1). Rather, having consensus on EDV allows us to select
LV concentric remodeling, LV hypertrophy, and diastolic
dysfunction as more fruitful targets.
. Comorbidities: one likely explanation for the 10% to 15%
of patients with HFNEF who have an increased EDV is
the presence of significant co-morbid conditions that
commonly increase intravascular volume. In the current
study, patients with HFNEF had a high prevalence of
anemia (19%), severe chronic renal failure (8%), obesity
(29%), coronary artery disease (58%), and diabetes mellitus
(30%) compared with the other 2 groups. The effects of
these co-morbid factors were not selectively examined in
the 10% of HFNEF patients with an increased EDV, but
they are likely to be co-dependent.
tudy limitations. The percentage of patients that fall
ithin versus outside the normal range in HFNEF is
ritically dependent on the inclusion and exclusion criteria
sed to define the population, and details of the methods,
rocedures, and technology used by a core echocardiography
aboratory. For example, depending on the inclusion and
xclusion criteria used, even data from the Cardiovascular
ealth Study have considerable variation (1,12,13). In 2
revious Cardiovascular Health Study publications, the
ean LV EDD in patients with HFNEF was not statisti-
ally different from the mean LV EDD in the control group.
n addition, when data from 3 Cardiovascular Health Study
ublications are compared, there is a difference between the
ean values of LV EDD in the control groups reported in
ach study. Therefore, even using a carefully run core
aboratory, differences in inclusion and exclusion criteria
ay create enough variability that the small differences in
he mean value of LV EDD in the HFNEF patients versus
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985JACC Vol. 49, No. 9, 2007 Zile and LeWinter
March 6, 2007:982–5 Editorial Commentontrol subjects reported in the study in this issue of the
ournal have limited clinical importance.
A patient characteristic that could account for variation in
V EDV between published studies is the extent of LV
ypertrophy. In this regard, compared with other published
atabases, the Cardiovascular Health Study database includes
atients with only mild LV hypertrophy as demonstrated by an
verage 1-mm increase in posterior wall thickness.
Another limitation of the current study is the use of a single
-mode short-axis dimension measurement to calculate EDV.
n addition, it was possible to make this M-mode measurement
f LV EDD in ONLY 86 of the 167 patients with HFNEF
i.e., ONLY 51%). Therefore, the study results are based on
6, not 167 patients, making this study of only modest size
nd/or power. It is also possible that the inability to make this
easurement systematically excluded certain patient groups in
hom echocardiographic windows are problematic.
Given these limitations, it is important to be cautious in
nterpreting these data. The authors of the current study
ropose that “extra-cardiac factors, via volume overload”
ontribute to the pathophysiology of DHF. However, pre-
ious studies have shown that patients with acutely decom-
ensated DHF actually have a reduced LV EDV compared
ith the EDV present after treatment (14,15). The authors
id not define nor did they examine any “extra-cardiac”
actors. If by this term they refer to changes in arterial
ompliance or ventricular-vascular coupling, 3 recent studies
ave shown that these factors do not play a role in the
evelopment of DHF (5,7,8). Instead, available evidence
uggests that the development of DHF primarily reflects
rogressive diastolic dysfunction (2–8).
onclusions. The great majority of patients with HFNEF
i.e., DHF) have a normal LV EDV. The pathophysiology
nderlying DHF reflects the development of progressive dia-
tolic dysfunction. When correctly interpreted, the study in this
ssue of the Journal supports these conclusions, removes any
emaining controversy regarding LV EDV in patients with
HF, and redefines a consensus in CHF pathophysiology.
eprint requests and correspondence: Dr. Michael R. Zile,
ivision of Cardiology, Department of Medicine, Medical Uni-
ersity of South Carolina, 135 Rutledge Avenue, Suite 1201, P.O.
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